- July 25, 2023
- Posted by: EBAN Team
- Category: Industry Reports, KNOWLEDGE CENTER
NLC’s Health Impact Fund is their latest flagship fund that aims to bridge this widening healthcare gap between innovation and the market. With a target size of €100 million, it will invest into a highly diversified portfolio of over 80 NLC ventures.
Actively managed by NLC’s Fund Management (FM) team, the Fund will invest from the pre-seed stage when value creation and return potential are the highest, with the potential to allocate up to €9m per company in follow-on financing for the most successful ventures up until Series A and Series B.
Their Health Impact Fund is the most diversified early-stage opportunity that addresses a major societal problem.
The FM and the Health Impact Fund are registered with the Dutch Authority for the Financial Markets (AFM).
More info below.
